Please use this identifier to cite or link to this item:
|Title:||Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures||Authors:||Tay, E.L.-W.
|Issue Date:||Feb-2008||Citation:||Tay, E.L.-W., Co, M., Tai, B.-C., Lee, Y.P., Low, A., Lim, Y.-T., Tan, H.-C., Lee, C.-H. (2008-02). Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures. Journal of Interventional Cardiology 21 (1) : 67-73. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1540-8183.2007.00291.x||Abstract:||Objective: We present our clinical experience of StarClose in patients undergoing coronary interventions, including its use in patients after repeated puncture of the same femoral access site. Background: The StarClose is a novel vascular closure device that deploys a small, flexible, circumferential nitinol clip onto the femoral artery surface. Methods: In this study, 103 consecutive patients (24% with repeated punctures) who underwent percutaneous coronary intervention and received a StarClose were followed up prospectively. The patients were assessed for vascular complications prior to hospital discharge. Device success, based on time-to-hemostasis, was divided into (1) immediate success: hemostasis achieved immediately after StarClose deployment without the need for adjunctive manual compression, (2) partial success: occurrence of minor oozing after StarClose deployment and hemostasis achieved after 3 minutes. Results: Immediate success, partial success, and device failure rates were 74% (n = 68), 16% (n = 15), and 10% (n = 9), respectively. There were no major complications attributable to the StarClose device. There were 10 (9.7%) cases of minor complications; all were recurrent wound bleeding requiring manual compression in the wards. Among these 10 cases of recurrent bleeding, 5 (50%) had initial device success (immediate success, n = 2, partial success, n = 3) in the catheterization laboratory. The risk for recurrent bleeding was 2.9% after immediate device success and 20.0% after partial device success. Conclusion: Our study found no major complications but a 10% failure rate and a 9.7% rate of minor complications. Close surveillance is important as there is a risk for recurrent bleeding, especially in patients with partial device success as defined in this report. © Authors.||Source Title:||Journal of Interventional Cardiology||URI:||http://scholarbank.nus.edu.sg/handle/10635/109249||ISSN:||08964327||DOI:||10.1111/j.1540-8183.2007.00291.x|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 28, 2021
WEB OF SCIENCETM
checked on Jul 28, 2021
checked on Aug 1, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.